Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on hormones and fertility. Browse all Hormones & Fertility education

Sexual response isn't one system — it's at least four, firing in sequence and feedback. Desire originates in the brain's dopamine circuits. Arousal engages central nervous system melanocortin signaling. Physical response depends on nitric oxide and the vascular smooth muscle it relaxes. Connection — intimacy, bonding, satisfaction — runs through oxytocin. When one of those systems is genetically underpowered, generic protocols miss. The Precision Peptide Genetic Test analyzes the genes that govern each system — part of a broader panel spanning 14 pathways, 49 peptides, and 150+ genetic insights. This pillar guide walks through what each gene measures, why sexual health is almost always a multi-system problem, and how to translate your results into an informed conversation with a qualified healthcare provider.

The Four Systems That Shape Sexual Response

Healthy sexual function is the output of four interconnected biological systems, each with its own genetic architecture. The vascular system — governed primarily by eNOS and the PDE5 gene family — handles blood flow and tissue response. The dopamine system — governed by DRD2 — handles desire, anticipation, and motivation. The oxytocin system — governed by OXTR — handles bonding, satisfaction, and the emotional quality of the experience. The circadian system — governed by MTNR1B and related timing genes — handles sleep, energy, and the rhythms that sexual function is deeply tied to. The 6 Sexual Health insights in the Precision Peptide Genetic Test map onto all four.

eNOS (NOS3) — The Nitric Oxide Engine

eNOS encodes endothelial nitric oxide synthase, the enzyme that produces nitric oxide (NO) in blood vessels. NO is the molecule that relaxes vascular smooth muscle — and vascular smooth muscle relaxation is what enables blood flow to sexual tissues. Common eNOS variants (rs1799983, rs2070744) influence baseline NO production. Lower eNOS output means less vasodilation capacity from the same stimulus. Relevant for understanding the PDE5 pathway (which works by preventing breakdown of NO's downstream messenger, cGMP) — and for whether nitric oxide precursor strategies like L-citrulline, L-arginine, or dietary nitrates are likely to move the needle.

DRD2 — Dopamine and Desire

DRD2 encodes dopamine receptor D2. Dopamine is the neurochemistry of anticipation, motivation, reward, and desire — and desire sits at the top of the sexual response cascade. Variants in DRD2 influence baseline dopamine receptor density and signaling sensitivity. Lower-sensitivity variants correlate with reduced libido, diminished anticipatory response, and blunted sexual motivation — even when vascular function is intact. This is why some people with perfect blood flow and normal hormones still experience low libido: the signal isn't firing at the top of the cascade.

OXTR — Oxytocin, Bonding, and the Intimacy Signal

OXTR encodes the oxytocin receptor. Oxytocin is the molecule of pair-bonding, orgasmic satisfaction, and the sense of connection that follows intimacy. Common OXTR variants (rs53576, among others) influence receptor sensitivity — shaping bonding behavior, emotional satisfaction, and the relational quality of sexual experience. OXTR isn't about whether arousal occurs; it's about what the experience feels like afterward, and whether it builds or erodes intimacy over time. Genetic variants here help explain why two people can have the same physical response but radically different emotional experiences.

MTNR1B — Circadian Rhythm and Sexual Function

MTNR1B encodes the melatonin receptor 1B, a key regulator of circadian rhythm. Sexual function is deeply circadian — testosterone peaks in the morning for men, arousal architecture shifts with sleep quality, and fatigue-driven libido suppression is one of the most common complaints in sexual health. MTNR1B variants affect melatonin signaling, sleep depth, and downstream energy availability. A sexual health issue that improves with sleep optimization often has an MTNR1B genetic component underneath.

PDE5 Gene Family — The Vasodilation Pathway at the Genetic Level

PDE5 encodes phosphodiesterase type 5, the enzyme that breaks down cGMP — the downstream messenger of nitric oxide in vascular smooth muscle. Genetic variants in the PDE5 gene family influence baseline PDE5 activity and how responsive the vascular system is to PDE5 pathway modulation. Paired with your eNOS profile, PDE5 variants complete the vascular side of the genetic picture. Some readers will have strong eNOS and less responsive PDE5; others the reverse. Both shape the conversation with a qualified provider about which pathway levers are most likely to help.

Beyond Sexual Health: How Your Panel Connects

Sexual health doesn't live in one pathway. Your 6 Sexual Health insights intersect with the 8 Mood insights (DRD2 crossover, stress biology that suppresses libido), the 6 Reproductive Health insights (testosterone and estrogen clearance shape the hormonal inputs), the 12 Energy Metabolism insights (mitochondrial function powers vascular and neural output), the 3 Sleep insights (circadian architecture), and the 15 Muscle Growth insights (cardiovascular fitness is foundational for vascular health). For a full overview of what the Precision Peptide Genetic Test covers, see our guide to genetic peptide testing. The Peptide Pathways Report synthesizes these cross-pathway findings into a single actionable roadmap.

Genetics as a Guide, Not a Guarantee

Your results don't diagnose any sexual health condition, and they don't prescribe a protocol. What they do is reveal the biological terrain your strategy has to operate on. A PDE5-sensitive, high-eNOS profile with less-sensitive DRD2 suggests the desire side of the cascade needs attention first. A high-responsive DRD2 with compromised eNOS suggests the vascular side. Same symptoms, completely different underlying genetic profiles — and completely different implications for a qualified provider to evaluate. The real win is replacing trial-and-error with decisions calibrated to your actual biology — the premise of testing before you invest in any sexual health protocol.

The Precision Peptide Genetic Test analyzes how your genes influence sexual health pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to see your sexual health genetic profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions

How many genes does sexual health testing cover in the PlexusDx panel?

The Precision Peptide Genetic Test analyzes sexual health genetics as part of 6 Sexual Health insights across 14 pathways, 49 peptides, and 150+ genetic insights. Core genes include eNOS, DRD2, OXTR, MTNR1B, and PDE5 gene family variants — covering vascular response, desire, bonding, and circadian function. Processed via Illumina Global Screening Array at CLIA-certified labs.

Why do some sexual health protocols work for some people but not others?

Genetics. Sexual response is a four-system interaction — vascular (eNOS, PDE5), dopamine (DRD2), bonding (OXTR), and circadian (MTNR1B). A protocol that targets the vascular system won't help someone whose primary issue is dopamine signaling, even if vascular labs look fine. The Precision Peptide Genetic Test reveals which system is your likely bottleneck.

Can genetic testing tell me if sexual health protocols will work?

No — the Precision Peptide Genetic Test informs the conversation, not the prescription. Your 6 Sexual Health insights reveal whether your likely bottleneck is vascular (eNOS), dopamine-driven (DRD2), bonding-related (OXTR), or circadian (MTNR1B). These shape how a qualified healthcare provider approaches a sexual health protocol — the prescription is theirs to make.

This article is part of the PlexusDx Education Hub. Browse all Hormones & Fertility education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.